GH Research PLC Ordinary Shares (GHRS)
Stock · NASDAQ · Health Care
$27.94as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$14.65
Industry
Biotechnology: Pharmaceutical Preparations
GH Research PLC Ordinary Shares Competitors
Chosen by industry and closest market cap.
- GHRSGH Research PLC Ordinary Shares$27.94▼ 2.48%Market cap $2.10BP/E —
- AUPHAurinia Pharmaceuticals Inc Ordinary Shares$16.3▼ 1.09%Market cap $2.10BP/E 6.39$10.34$19.25
- NUVBNuvation Bio Inc. Class A Common Stock$6.67▼ 4.65%Market cap $2.13BP/E —$2.87$9.75
- HCMHUTCHMED (China) Limited American Depositary Shares$12.4▼ 0.12%Market cap $2.06BP/E 4.74$15.57$28.8
- STOKStoke Therapeutics Inc. Common Stock$31.61▼ 3.01%Market cap $2.06BP/E —$18.8$40.22
- ZBIOZenas BioPharma Inc. Common Stock$31.29▼ 4.08%Market cap $2.03BP/E —$13.5$44.6
- BHVNBiohaven Ltd. Common Shares$15.42▼ 4.37%Market cap $2.17BP/E —$7.48$18.57
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GHRS GH Research PLC Ordinary Shares | $2.10B | — | $27.94 | ▼ 2.48% | |
| AUPH Aurinia Pharmaceuticals Inc Ordinary Shares | $2.10B | 6.39 | $16.3 | ▼ 1.09% | $10.34$19.25 |
| NUVB Nuvation Bio Inc. Class A Common Stock | $2.13B | — | $6.67 | ▼ 4.65% | $2.87$9.75 |
| HCM HUTCHMED (China) Limited American Depositary Shares | $2.06B | 4.74 | $12.4 | ▼ 0.12% | $15.57$28.8 |
| STOK Stoke Therapeutics Inc. Common Stock | $2.06B | — | $31.61 | ▼ 3.01% | $18.8$40.22 |
| ZBIO Zenas BioPharma Inc. Common Stock | $2.03B | — | $31.29 | ▼ 4.08% | $13.5$44.6 |
| BHVN Biohaven Ltd. Common Shares | $2.17B | — | $15.42 | ▼ 4.37% | $7.48$18.57 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.